CETUXIMAB ERBITUX

Welcome to the Brand page for “CETUXIMAB ERBITUX”, which is offered here for The mark comprises the words cetuximab erbitux and an antibody design (shown in stippling);pharmaceutical preparation, monoclonal antibody for the treatment of cancer;cetuximab;-;.

Its status is currently believed to be active. Its class is unavailable. “CETUXIMAB ERBITUX” is believed to be currently owned by “IMCLONE SYSTEMS INCORPORATED”.

Owner:
IMCLONE SYSTEMS INCORPORATED
Owner Details
Description:
THE MARK COMPRISES THE WORDS CETUXIMAB ERBITUX AND AN ANTIBODY DESIGN (SHOWN IN STIPPLING);PHARMACEUTICAL PREPARATION, MONOCLONAL ANTIBODY FOR THE TREATMENT OF CANCER;CETUXIMAB;-;
Categories: MARK COMPRISES